| |
Dr Suthakaran Chidambarann |
| |
Madras Medical College Madras Madras University,Chennai
MD Pharmacology, 1975-1983 Thanjavur Medical College Thanjavur Madras University
MBBS |
|
| |
2008 April to Till date
Head Clinical Research Services
Madras Diabetes Research Foundation Chennai
- Initiated seven Phase II and III clinical trials
- Reorganised the Human Ethics committee
- Developed SOP for smooth functioning of the research unit
- Developed 17 Work Instructions
- Developed 32 SOP for the smooth functioning of Ethics committee
- Developed application format for research proposals
- Developed the approval format for research proposals
- Trained 16 personnel in GCP
- Initiated publication of MDRF News letter
- Editor of Drug A Month publication
- Drug Information Services for Diabetologists
- Three articles in advanced stages of publication
|
| |
Jan 2007 –Mar 2008
Accenture Services Limited Chennai
General Manager Operations
- Initiated and developed Outsourcing of Pharmacovigilance services
- Looked after 3 of the 5 pillars of Pharmacovigilance (Safety Reporting Medical Review and Case Validation)
- Managed 67 professionals of 3 teams in two shifts
- Implemented training course for new recruits
|
Feb 2006 to Dec 2006
The Himalaya Drug Company Bangalore
Medical Advisor
- Initiated sixteen clinical trials for various products
- Trained the senior manager in product knowledge
- Expanded the publication activities of the company
|
1998 –2005
Stedman Pharmaceuticals P Limited Chennai
Medical Director
- Responsible for introduction of new products
- Identification of new products
- Training of field personnel
- Research and Development of new drug combinations
- Introduced several first time combinations - Drez (Topical povidone iodine plus Metonidazole) , Serronak (Diclofenac sodium plus Serratiopeptidase), Restofit Capsules (Vitamin E plus N-Acetyl cysteine), Nimuspas (Nimesulide plus dicyclomine)
- Responsible for registering the company’s products in Sri Lanka, Tanzania, Vietnam Myanmmar.
1992 –1998 Croslands (Ranbaxy) Mumbai
Manager Regulatory & Clinical Research Services
- Responsible for introduction of new products such as Daivonex (Calcipotriol)
- Identification of new products such as Volini Gel Tiniflox (Tinidazole plus norfloxacin), Croaml (amlodipine plus atenolol) Hydralac (Clobetasol plus Ammonium Lactate) Volini Gel
- Training of field personnel
- Research and Development of new drug combinations
- Responsible for registering the company’s products in Sri Lanka, Tanzania, Vietnam Myanmmar Uganda Kenya
- Liaise and coordinate with international collaborators to get their products registered in India.
- Responsible for the development of technical reports, preparation of protocol/proforma and identification of investigators
- Proficiently coordinating with formulation R &D, Finance, Collection of results and Analysis of results.
- Managing the report compilation and report submission with reports for submission to Regulatory authorities.
- Handling the in-vitro release pattern of creams, pre marketing assessment studies and post-marketing surveillance studies.
- Proficiently answering medical queries, accountable for the literature collection and training field personnel.
- Effectively manage/develop the justification and scientific literature for company products.
1989–1992 JIPMER Pondicherry
Senior Demonstrator
- Foremost in-charge of Therapeutic Monitoring Unit simultaneously teaching the MBBS and MD students.
- Responsible to assist Dr C Adithan in conducting bio-availability & pharmacokinetic studies and in the conduct of animal pharmacology studies
- Initiated ADR services in collaboration with WHO
|
|
| |
- Ramasamy S Suthakaran C Bapna JS Role of GABA-ergic system in metoclopromide and clonidine analgesia Med Sci Res; 17:375-376.
- Ramasamy S Suthakaran C Bapna JS Role of GABA-ergic system in prolactin analgesia Clin Expl Physiol Pharmacol; 16:893-896.
- Rajasekaran M Suthakaran C Bapna JS Nair AG Mast cell protective activity of ursolic acid Drug Dev Res; 2:179-182 (Awarded the Uvans Prize)
- Adithan C Senthivel kumar B Raveendran R Suthakaran C DAs AK Bapna JS Increased elimination of phenytoin in undernourished type I diabetic patients Ind J Pharmacol; 22:211-215.
- Suthakaran C Vijayasekaran V Thanikachalam S Clinical evaluation of slow release nifedipine in mild to moderate hypertension (Paper presented in 12th Southern regional Conference of Indian Pharmacological Society Manipal.
- Suthakaran C Vijayasekaran V Thanikachalam S Clinical evaluation of atenolol in mild to moderate hypertension (Paper presented in 2nd International Conference of Clinical Pharmacology at Mumbai
- Suthakaran C Adithan C Rajaram S Compartive bioavailability of two different brands of ciprofloxacin Int J Clin Pharmacol Toxicol; 30:66-68.
- Suthakaran C Adithan C Rajaram S Sashindran CH Tripath KD Gandhi IS. Pharmacokinetics of ciprofloxacin- Limitations to salivary sampling Ind J Pharmacol; 24:25-28. (Awearded UK Seth Prize).
- Rajaram S Suthakaran C Bapna JS Majumdar Double blind randomized clinical trial of cetirizine in the treatment of seasonal allergic rhinitis Ind J Pharmacol;26: 112-116
|
|
| |
- Honored with the B.Uvnas Prize by the Indian Pharmacological Society in the year 1990 for the best work carried out in an Indian Laboratory on Autocoid Pharmacology.
- Bestowed with the U.K. Seth Prize by the Indian Pharmacological society in the year 1991 for the best work in Clinical Pharmacology in an Indian Laboratory
|
